BioAdvance Capital
Conshohocken, Pennsylvaniabioadvance.org
Overview
BioAdvance is an early-stage venture capital firm dedicated to advancing human health. They invest in therapeutics, medical devices, digital health, diagnostics, and research tools, primarily focusing on seed and Series A opportunities in the Mid-Atlantic region from New York City to Washington, D.C. BioAdvance provides funding to enable companies to reach critical milestones.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Latus Bio | May 2026 | Series A | Co-investor |
| BobcatBio | Feb 2025 | Series A Extension | Lead |
| Bobcat Bio | Feb 2025 | Series A Extension | Co-investor |
| Tolerance Bio, Inc. | Dec 2024 | Seed | Co-investor |
| Palvella Therapeutics | Dec 2024 | Private Placement | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
